Trial Profile
Study of comparison of pharmacodynamic effects of ticagrelor vs prasugrel in type 2 diabetes mellitus patients with coronary heart disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Nov 2018
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Acute coronary syndromes
- Focus Pharmacodynamics; Therapeutic Use
- 21 Nov 2018 New trial record